216 related articles for article (PubMed ID: 1976410)
21. L-Aspartate binding sites in rat cerebellum: a comparison of the binding of L-[3H]aspartate and L-[3H]glutamate to synaptic membranes.
Sharif NA; Roberts PJ
Brain Res; 1981 May; 211(2):293-303. PubMed ID: 6113029
[TBL] [Abstract][Full Text] [Related]
22. CPP, a selective N-methyl-D-aspartate (NMDA)-type receptor antagonist: characterization in vitro and in vivo.
Lehmann J; Schneider J; McPherson S; Murphy DE; Bernard P; Tsai C; Bennett DA; Pastor G; Steel DJ; Boehm C
J Pharmacol Exp Ther; 1987 Mar; 240(3):737-46. PubMed ID: 2882014
[TBL] [Abstract][Full Text] [Related]
23. [Effects of N-phthalamoyl-L-glutaminic acid, a selective agonist of NMDA receptor, on binding of 3H-L-glutamate with synaptic membranes of the hippocampus].
Koreshonkov ON; Perestenko PV; Dumpis MA; Piotrovskiĭ LB
Biull Eksp Biol Med; 1992 Jun; 113(6):563-5. PubMed ID: 1446016
[TBL] [Abstract][Full Text] [Related]
24. Distribution of N-methyl-D-aspartate-sensitive L-[3H]glutamate-binding sites in rat brain.
Monaghan DT; Cotman CW
J Neurosci; 1985 Nov; 5(11):2909-19. PubMed ID: 2865341
[TBL] [Abstract][Full Text] [Related]
25. Heterogeneity of the N-methyl-D-aspartate receptor ionophore complex in rat brain, as revealed by ligand binding techniques.
Yoneda Y; Ogita K
J Pharmacol Exp Ther; 1991 Oct; 259(1):86-96. PubMed ID: 1681092
[TBL] [Abstract][Full Text] [Related]
26. Effects of anti-glutamate-binding protein antibodies on synaptic membrane ion flux, glutamate transport and release, and L-glutamate binding activities.
Roy S; Galton N; Michaelis E
J Neurochem; 1985 Jun; 44(6):1809-15. PubMed ID: 2859356
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and biological evaluation of cyclopropyl analogues of 2-amino-5-phosphonopentanoic acid.
Dappen MS; Pellicciari R; Natalini B; Monahan JB; Chiorri C; Cordi AA
J Med Chem; 1991 Jan; 34(1):161-8. PubMed ID: 1671413
[TBL] [Abstract][Full Text] [Related]
28. Characteristics of chloride-dependent incorporation of glutamate into brain membranes argue against a receptor binding site.
Zaczek R; Arlis S; Markl A; Murphy T; Drucker H; Coyle JT
Neuropharmacology; 1987 Apr; 26(4):281-7. PubMed ID: 2884589
[TBL] [Abstract][Full Text] [Related]
29. Analysis of L-[3H]-glutamate radioligand binding to plasma membranes of the ampullae of Lorenzini of skates.
Akoev GN; Dambinova SA; Ryzhova IV; Gorodinsky AI
Neuroreport; 1993 Sep; 4(10):1197-9. PubMed ID: 8106003
[TBL] [Abstract][Full Text] [Related]
30. A study in rat brain cortex synaptic vesicles of endogenous ligands for N-methyl-D-aspartate receptors.
Villanueva S; Fiedler J; Orrego F
Neuroscience; 1990; 37(1):23-30. PubMed ID: 2147052
[TBL] [Abstract][Full Text] [Related]
31. The pharmacological specificity of N-methyl-D-aspartate receptors in rat cerebral cortex: correspondence between radioligand binding and electrophysiological measurements.
Grimwood S; Foster AC; Kemp JA
Br J Pharmacol; 1991 Jun; 103(2):1385-92. PubMed ID: 1832067
[TBL] [Abstract][Full Text] [Related]
32. In vivo study of NMDA-sensitive glutamate receptor by fluorothienylcyclohexylpiperidine [correction of fluorothienylcycloexylpiperidine], a possible ligand for positron emission tomography.
Ferrarese C; Guidotti A; Costa E; Miletich RS; Rice KC; de Costa BR; Fulham MJ; Di Chiro G
Neuropharmacology; 1991 Aug; 30(8):899-905. PubMed ID: 1685770
[TBL] [Abstract][Full Text] [Related]
33. Binding of [3H]3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid to rat brain membranes: a selective, high-affinity ligand for N-methyl-D-aspartate receptors.
Murphy DE; Schneider J; Boehm C; Lehmann J; Williams M
J Pharmacol Exp Ther; 1987 Mar; 240(3):778-84. PubMed ID: 3031274
[TBL] [Abstract][Full Text] [Related]
34. Glutamate receptor changes in brain synaptic membranes from human alcoholics.
Michaelis EK; Freed WJ; Galton N; Foye J; Michaelis ML; Phillips I; Kleinman JE
Neurochem Res; 1990 Nov; 15(11):1055-63. PubMed ID: 1982456
[TBL] [Abstract][Full Text] [Related]
35. Two classes of N-methyl-D-aspartate recognition sites: differential distribution and differential regulation by glycine.
Monaghan DT; Olverman HJ; Nguyen L; Watkins JC; Cotman CW
Proc Natl Acad Sci U S A; 1988 Dec; 85(24):9836-40. PubMed ID: 2904680
[TBL] [Abstract][Full Text] [Related]
36. Characteristics of [3H]glutamate binding sites in rat cerebellum.
Rao VL; Murthy CR
Biochem Mol Biol Int; 1993 Aug; 30(5):861-6. PubMed ID: 8106070
[TBL] [Abstract][Full Text] [Related]
37. Characterization of spermidine-dependent [3H](+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine (MK-801) binding in brain synaptic membranes treated with Triton X-100.
Yoneda Y; Ogita K; Enomoto R
J Pharmacol Exp Ther; 1991 Mar; 256(3):1161-72. PubMed ID: 1826032
[TBL] [Abstract][Full Text] [Related]
38. Spider venoms inhibit L-glutamate binding to brain synaptic membrane receptors.
Michaelis EK; Galton N; Early SL
Proc Natl Acad Sci U S A; 1984 Sep; 81(17):5571-4. PubMed ID: 6147850
[TBL] [Abstract][Full Text] [Related]
39. L-[3H]Glutamate binds to kainate-, NMDA- and AMPA-sensitive binding sites: an autoradiographic analysis.
Monaghan DT; Yao D; Cotman CW
Brain Res; 1985 Aug; 340(2):378-83. PubMed ID: 2862960
[TBL] [Abstract][Full Text] [Related]
40. Radioligand labeling of N-methyl-D-aspartic acid (NMDA) receptors by [3H](+-)-3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid in brain synaptic membranes treated with Triton X-100.
Yoneda Y; Ogita K; Kouda T; Ogawa Y
Biochem Pharmacol; 1990 Jan; 39(1):225-8. PubMed ID: 2153381
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
